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S63ABSTRACTS / Biochimica et Biophysica Acta 1777 (2008) S2–S111conditions. These results demonstrate the presence of iPLA2 in lung
mitochondria and support the hypothesis that the activation of
mitochondrial phospholipases by mild oxidative stress can provide
free fatty acids as cycling substrates for UCP2. However, attenuation of
ROS production by UCP2 is not signiﬁcant.
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We have studied the quinone structural features that confer
modulatory properties on the mitochondrial permeability transition
pore (PTP). Reduced derivatives of ubiquinone (Ub) 0 with acetoxy or
methoxy substitutions of the carbonyl groups became ineffective at
PTP inhibition. Consistent with a key role of the Ub0 oxidation-
reduction state for its interactions with the PTP, DTT prevented the
inhibitory effects on the pore when added before but not after Ub0. Of
note, the addition of DTT after Ub0 prevented the toxic effects of Ub0
on respiration. The combination of Ub0 and DTT thus allowed
inhibition of the PTP without mitochondrial toxicity, which in the
absence of DTT reveals itself with a bell-shaped curve where the Ub0-
dependent increase of mitochondrial Ca2+ retention capacity (a
measure of PTP inhibition) is superceded by a decrease as the Ub0
concentration is raised above about 50 μM. The PTP inhibitory effects
of decylUb were instead unaffected by reducing agents, and Ub0 and
decylUb displayed additive effects on PTP inhibition, indicating that
they act at different inhibitory sites on the PTP.
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Synthesized in the Skulachev's laboratory new type of mitochon-
dria-targeted antioxidants — plastoquinone derivatives (SkQs) were
investigated. The aim of our study was to estimate of antioxidant
properties of the SkQ family members plastoquinonyl decyltriphe-
nylphosphonium (SkQ1) and plastoquinonyl decylrhodamin 19
(SkQR1), a ﬂuorescent derivative. These compounds combined with
a positively-charged penetrating cations were selectively targeted to
mitochondria, being accumulated inside, and can be reduced by the
respiratory chain. Using confocal microscope we observed that SkQR1
was accumulated bymitochondria. Uncoupling action of FCCP, leading
to mitochondrial depolarization, prevented the SkQR1 staining. In
human cell cultures HeLa and K562 very low concentrations
(nanomolar) of antioxidants were found to prevent ROS-induced
apoptosis and necrosis. Oxidative stress initiated by addition of small
amount H2O2 to living cells, caused secondary generation of
endogenous ROS and lowered the level of reduced glutathione.SkQ1 and SkQR1 prevented oxidative damage as well as glutathione
oxidation, C1/2 being around 2nM and 0.5 nM respectively. It is
concluded that cationic plastoquinone derivatives are rechargeable,
mitochondria-targeted antioxidants of very high efﬁciency.
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Our aimwas to analyse the effects of VP on the production of ROS by
lymphocytes and determine the possible mitochondrial sources of
these ROS. Twelve women affected by VP and twelve control healthy
women participated in the study. H2O2 production was measured
using 2,7-dichloroﬂuorescin-diacetate as indicator in basal conditions
and after stimulation with PMA. In addition three treatments with
allopurinol, rotenone or myxothiazol were performed in PMA-
stimulated lymphocytes. No differences were observed between
porphyric and control women in the basal production of H2O2. The
stimulation with PMA increased H2O2 production in both groups but
lymphocytes from porphyric women produced higher levels of H2O2
than controls. The treatments with allopurinol and rotenone did not
modify H2O2 production but after treatment with myxothiazol H2O2
production decreased back to basal levels in both groups. In
conclusion, lymphocytes from women affected by VP produce the
same amount of H2O2 in basal conditions than control women, but
after stimulation lymphocytes from porphyric women produce higher
levels of H2O2. This increased H2O2 production is due to an impaired
function of the mitochondrial respiratory chain rather than to other
ROS sources such as xanthine oxidase.
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Camptothecin (CPT), a topoisomerase I inhibitor, is used for treat-
ment of certain types of malignancies. Uncoupling protein 2 (UcP2) is
proposed to protect cardiomyocytes against oxidative stress. Modula-
tion of UcP2 level appears important because the protein increases in
failing human heart. p38MAPK belongs to a group of protein serine/
threonine kinases that become activated in response to extracellular
stimuli and mediate signal transduction in cell growth, differentiation
and apoptosis. We found that CPT treatment induces UcP2 expression
on both mRNA and protein level in cardiomyocytes. This induction is
accompanied by short-term increase in production of ROS (b1 h)
preceded by activation of p38MAPK (b30 min). Activation of p38MAPK
by CPT was comparable to anisomycin, a protein synthesis inhibitor
that activates stress-related MAPKs, namely p38MAPK in mammalian
cells. Pretreatment of cardiomyocytes with p38MAPK inhibitor,
SB203580, blocked activation of p38MAPK by both compounds and
abolished the camptothecin-mediated UcP2 induction. Our results
